Study results of Ayurvedic treatment on COVID patients using proprietary herbal formulation SUVED and whole colostrum REIMMUGEN.

Integration of Ayurvedic proprietary formulation (SUVED) and Whole Colostrum (REIMMUGEN) intervention given together, to reduce morbidity and mortality in suspected and confirmed COVID patients admitted to COVID ward in Pune. - SU-REM-COVID

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025343

Enrollment

Registered

2020-05-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B342- Coronavirus infection, unspecified

Interventions

Intervention1: proprietary Ayurvedic SUVED: Whole Colostrum REIMMUGEN: Oral, additional, Ayurvedic intervention given for 15 days in addition to ongoing treatment. DOSAGE SUVED capsules. 1 BD, Reimmu

dosage 1 TDS with plenty water before meals Control Intervention1: not applicable: COVID treatment protocol

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to COVID ward; symptomatic or non-symptomatic. Patients under observation in COVID quarantine.

Exclusion criteria

Exclusion criteria: Below age 18, pregnant and lactating women; Patients in COVID ICU with ventilator support.

Design outcomes

Primary

Measure	Time frame
MortalityTimepoint: 15 days or at discharge for any reason	—

Secondary

Measure	Time frame
MorbidityTimepoint: 15 days or at discharge for any reason	—

Countries

India

Contacts

Public ContactSujata Vaidya

Health Solutions

drsujatavaidya@gmail.com9822311565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026